Mycobacterium tuberculosis is an acid-fast, human-specific pathogen and is the etiological agent of the respiratory disease tuberculosis (TB). Approximately 2 billion individuals are currently predicted to be latently infected with the tuberce bacillus. During latency, M. tuberculosis exists within host-generated granulomatous lesions in a poorly understood physiological state termed non-replicating persistence (NRP). It is generally thought that specific conditions initially encountered within granulomatous lesions, including oxygen-limitation and nitric oxide, inhibit aerobic respiration and induce the transition of M. tuberculosis into NRP for long-term survival during anaerobic dormancy. Aerobic and anaerobic respiration in M. tuberculosis is mediated in part by NADH dehydrogenases (NDH), enzymes which catalyze the oxidation of NADH to NAD+ with concomitant transfer of electrons to respiratory chain components. M. tuberculosis encodes one type-1 NDH and two type-2 NDHs. Recently, we identified a third predicted type-2 NDH (Rv1812c) that is regulated by determinants/conditions associated with M. tuberculosis persistence. Preliminary investigations described in this application indicate that Rv1812c encodes a type-2 NDH and participates in the resuscitation of M. tuberculosis from anaerobic dormancy. In addition, we provide bioinformatic evidence indicating that Rv1812c possesses unique structural, functional, and expression characteristics that distinguish it from the other two established type-2 NDHs (Ndh and NdhA) produced in M. tuberculosis. The two specific aims proposed in this application will allow us to investigate and compare the activities of the three type-2 NDHs produced in M. tuberculosis, and determine whether Rv1812c is required for M. tuberculosis NRP or its resuscitation from latency in vivo.

Public Health Relevance

Mycobacterium tuberculosis is the causative agent of tuberculosis, a disease associated with significant morbidity and mortality worldwide. M. tuberculosis is capable of establishing lifelong asymptomatic infections in susceptible individuals and reactivating during periods of immune suppression to cause active disease. M. tuberculosis determinants important for persistent infection or reactivation from latency are poorly understood. In this application, we will investigate a predicted type-2 NADH dehydrogenase, Rv1812c, to determine its role in M. tuberculosis physiology and virulence. This determinant may represent a novel therapeutic target for therapeutic intervention against this organism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI111025-02
Application #
8990817
Study Section
Special Emphasis Panel (ZRG1-IDM-B (80))
Program Officer
Kraigsley, Alison
Project Start
2015-01-01
Project End
2016-12-31
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
2
Fiscal Year
2016
Total Cost
$229,500
Indirect Cost
$79,500
Name
Medical College of Wisconsin
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226